PL348107A1 - Therapy for improving cognition - Google Patents
Therapy for improving cognitionInfo
- Publication number
- PL348107A1 PL348107A1 PL99348107A PL34810799A PL348107A1 PL 348107 A1 PL348107 A1 PL 348107A1 PL 99348107 A PL99348107 A PL 99348107A PL 34810799 A PL34810799 A PL 34810799A PL 348107 A1 PL348107 A1 PL 348107A1
- Authority
- PL
- Poland
- Prior art keywords
- therapy
- improving cognition
- cognition
- improving
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203454 | 1998-10-16 | ||
| PCT/EP1999/007804 WO2000023057A2 (fr) | 1998-10-16 | 1999-10-12 | Therapie visant a ameliorer la cognition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL348107A1 true PL348107A1 (en) | 2002-05-06 |
Family
ID=8234219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99348107A PL348107A1 (en) | 1998-10-16 | 1999-10-12 | Therapy for improving cognition |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1121131A2 (fr) |
| JP (1) | JP2002527469A (fr) |
| KR (1) | KR20010072878A (fr) |
| CN (1) | CN1367697A (fr) |
| AU (1) | AU6472799A (fr) |
| BG (1) | BG105302A (fr) |
| BR (1) | BR9914419A (fr) |
| CA (1) | CA2345767A1 (fr) |
| EE (1) | EE200100136A (fr) |
| HK (1) | HK1039745A1 (fr) |
| HR (1) | HRP20010262A2 (fr) |
| HU (1) | HUP0103781A3 (fr) |
| ID (1) | ID28441A (fr) |
| IL (1) | IL142588A0 (fr) |
| NO (1) | NO20011403L (fr) |
| PL (1) | PL348107A1 (fr) |
| SK (1) | SK4592001A3 (fr) |
| TR (1) | TR200101082T2 (fr) |
| WO (1) | WO2000023057A2 (fr) |
| ZA (1) | ZA200103081B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
| AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
| JP5067998B2 (ja) | 2001-10-30 | 2012-11-07 | ノバルティス アーゲー | イロペリドンおよび星形ポリマーのデポー製剤 |
| GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
| WO2004084905A2 (fr) * | 2003-03-24 | 2004-10-07 | University Of Florida | Methodes de traitement de l'hyperhidrose idiopathique et de pathologies associees |
| TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
| EP1824848A1 (fr) * | 2004-12-10 | 2007-08-29 | Abbott Laboratories | Derives polycycliques de quinuclidine substitues par un bicycloheterocycle condense |
| EP1776089A2 (fr) * | 2003-12-31 | 2007-04-25 | Actavis Group hf | Formulations de donepezil |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| NZ579310A (en) | 2007-03-01 | 2012-03-30 | Probiodrug Ag | Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof |
| DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
| MX2007008642A (es) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias. |
| CA2789014C (fr) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Procedes et compositions pour ameliorer la fonction cognitive |
| EP2542549B1 (fr) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Inhibiteurs de glutaminyl cyclase |
| BR112012022478B1 (pt) | 2010-03-10 | 2021-09-21 | Probiodrug Ag | Inibidores heterocíclicos de glutaminil ciclase (qc, ec 2.3.2.5), seu processo de preparação, e composição farmacêutica |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| WO2014078568A1 (fr) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Méthodes et compositions pour le traitement de la schizophrénie |
| US11160785B2 (en) | 2013-03-15 | 2021-11-02 | Agenebio Inc. | Methods and compositions for improving cognitive function |
| EP3827820A1 (fr) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam pour améliorer la fonction cognitive |
| BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992020327A1 (fr) * | 1991-05-14 | 1992-11-26 | Ernir Snorrason | Traitement des etats de fatigue a l'aide d'inhibiteurs de cholinesterase |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| WO1999007378A1 (fr) * | 1997-08-11 | 1999-02-18 | THE UNIVERSITY OF SOUTH FLORIDA A Corporation of the State of Florida | Antagonistes de la nicotine destines a des troubles neuropsychiatriques sensibles a la nicotine |
| AU765603C (en) * | 1998-04-14 | 2004-08-05 | General Hospital Corporation, The | Methods for treating neuropsychiatric disorders |
-
1999
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 EP EP99952580A patent/EP1121131A2/fr not_active Withdrawn
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
- 1999-10-12 CA CA002345767A patent/CA2345767A1/fr not_active Abandoned
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Application Discontinuation
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/fr not_active Application Discontinuation
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/no not_active Application Discontinuation
- 2001-04-10 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
-
2002
- 2002-01-10 HK HK02100158.6A patent/HK1039745A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6472799A (en) | 2000-05-08 |
| CN1367697A (zh) | 2002-09-04 |
| NO20011403D0 (no) | 2001-03-20 |
| EE200100136A (et) | 2002-06-17 |
| ZA200103081B (en) | 2002-07-12 |
| HK1039745A1 (zh) | 2002-05-10 |
| TR200101082T2 (tr) | 2001-09-21 |
| HUP0103781A2 (hu) | 2002-03-28 |
| BG105302A (en) | 2001-11-30 |
| WO2000023057A2 (fr) | 2000-04-27 |
| EP1121131A2 (fr) | 2001-08-08 |
| ID28441A (id) | 2001-05-24 |
| WO2000023057A3 (fr) | 2000-07-27 |
| CA2345767A1 (fr) | 2000-04-27 |
| NO20011403L (no) | 2001-03-20 |
| BR9914419A (pt) | 2001-06-26 |
| JP2002527469A (ja) | 2002-08-27 |
| IL142588A0 (en) | 2002-03-10 |
| KR20010072878A (ko) | 2001-07-31 |
| HRP20010262A2 (en) | 2002-06-30 |
| HUP0103781A3 (en) | 2003-09-29 |
| SK4592001A3 (en) | 2001-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL348107A1 (en) | Therapy for improving cognition | |
| AP2002002661A0 (en) | Combination therapy for oesteoporosis | |
| GB9816263D0 (en) | Therapeutic agents | |
| GB9806102D0 (en) | Therapeutic agents | |
| EP1077704A4 (fr) | Therapie combinee destinee au traitement de la depression | |
| GB9804885D0 (en) | Therapeutic combination | |
| GB9808663D0 (en) | Therapeutic agents | |
| GB9801234D0 (en) | Therapeutic agents | |
| GB9813576D0 (en) | Therapeutic agents | |
| GB9813006D0 (en) | Therapeutic agents | |
| GB9801210D0 (en) | Therapeutic agents | |
| GB9816556D0 (en) | Therapy | |
| AP9901436A0 (en) | Therapeutic agents | |
| GB9801397D0 (en) | Therapeutic agents | |
| HUP0101947A3 (en) | Combination for the treatment of tumors | |
| GB9801202D0 (en) | Therapeutic agents | |
| GB9808665D0 (en) | Therapeutic compounds | |
| GB9824897D0 (en) | Therapeutic compounds | |
| GB9810092D0 (en) | Therapeutic agents | |
| GB9811879D0 (en) | Therapeutic agents | |
| GB9815317D0 (en) | Therapeutic agents | |
| GB0020261D0 (en) | Therapeutic treatment | |
| GB9805716D0 (en) | Therapeutic agents | |
| GB9808667D0 (en) | Therapeutic compounds | |
| GB9818524D0 (en) | Inorgasmia treatment |